Supplements such as curcumin, vitamin D, inositol, berberine, and chasteberry may help improve PCOS symptoms, especially when ...

ASCO 2025 overall survival data bolster IMNN-001’s potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism of ...

PCOS-related acne falls under the hormonal acne umbrella. While this term isn’t an official medical diagnosis, dermatologists ...

In addition to a significant PFS benefit vs nab-paclitaxel alone, the combination provides an at-home option for patients with ovarian cancer.

Ozempic is FDA-approved for treating type 2 diabetes – but could it also help with other conditions like PCOS Read on to find ...

Kancera AB (publ) (Kancera) today reports the top-line results from the KANDOVA study, a one-arm, open-label, multi-centre ...

The FDA grants fast track designation to PHST001, an antibody targeting CD24, for advanced platinum-resistant and ...

This open-label study enrolled 112 patients who were ... with advanced peritoneally metastasized primary or recurrent ovarian cancer and completed a Phase 1b dose-escalation trial (the OVATION ...

Corcept's trial hit a home run, H.C. Wainwright analyst Swayampakula Ramakanth said, adding that relacorilant could potentially receive a broader label than ... the company. Ovarian cancer affects ...

Updated results from RAINFOL-01 showed that heavily pretreated patients with advanced ovarian cancer who were treated with Rina ... Because it is still phase 2 data, it is not currently under an FDA ...

A team of researchers from the University of Michigan earned recognition from Forbes magazine contributor Juergen Eckhardt for creating the first comprehensive map of the human ovary. Forbes named the ...

2 MIRASOL is a global, phase 3 open-label, randomized ... 1 Eligible patients had platinum-resistant, high-grade serous ovarian cancer with tumors expressing high levels of FRα (≥ 75% of ...